Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Publication Of Nutra Pharma Corp.'s (NPHC) Patented Nyloxin™ Treatment Increases International Distribution Opportunity 0 comments
    Mar 26, 2013 11:08 AM | about stocks: NPHC

    Nutra Pharma Corp., a biotechnology company focused on the development of treatments for neurological disorders, cancer, autoimmune, infectious diseases, and pain, said that its patent and trademarks for the company's Nyloxin™ line of pain relievers have been published in India's Official Journal.

    This publication opens the door for patent and brand protection, which the company expects will result in eventual sales through Indian distributors.

    "The patent and trademark publications in India represent one of the more significant international market opportunities for Nyloxin," Rik J. Deitsch, chairman and CEO of Nutra Pharma stated in the press release. "Now that we have patent protection to protect our formulas and trademark protection to defend the brand we can work to create sales and distribution in India. With the population of India exceeding a billion people and with limited patient access to opioid-based pain relievers throughout the country, India represents a potentially significant customer base for Nyloxin."

    Nyloxin is currently available in the United States as an over-the-counter oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress. Additionally, Nyloxin is offered in an extra strength formula for advanced chronic pain.

    The patent entitled, "Use of Cobratoxin as an Analgesic," was published in the Official Journal No.: 09/2013 of the Indian Patent Office (NYSEARCA:IPO) on March 1, 2013.

    For more information, visit NutraPharma.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: NPHC
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.